BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
QuintilesIMS
McKesson
Queensland Health
Chubb
UBS
Fish and Richardson
Merck
Covington
Boehringer Ingelheim

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077246

« Back to Dashboard

NDA 077246 describes DANAZOL, which is a drug marketed by Am Therap, Barr, and Lannett, and is included in three NDAs. It is available from four suppliers. Additional details are available on the DANAZOL profile page.

The generic ingredient in DANAZOL is danazol. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the danazol profile page.
Summary for 077246
Tradename:DANAZOL
Applicant:Lannett
Ingredient:danazol
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Pharmacology for NDA: 077246
Ingredient-typeAndrostanes
Mechanism of ActionAndrogen Receptor Agonists
Medical Subject Heading (MeSH) Categories for 077246
Suppliers and Packaging for NDA: 077246
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DANAZOL danazol CAPSULE;ORAL 077246 ANDA Lannett Company, Inc. 0527-1369 0527-1369-01 100 CAPSULE in 1 BOTTLE (0527-1369-01)
DANAZOL danazol CAPSULE;ORAL 077246 ANDA Lannett Company, Inc. 0527-1369 0527-1369-06 60 CAPSULE in 1 BOTTLE (0527-1369-06)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength200MG
Approval Date:Sep 28, 2005TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength50MG
Approval Date:Apr 19, 2007TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100MG
Approval Date:Apr 19, 2007TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Novartis
Boehringer Ingelheim
Dow
Farmers Insurance
AstraZeneca
Federal Trade Commission
Chinese Patent Office
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot